Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?
Abdul‐rizaq Hamoud(ProMedica Toledo Hospital), Sinead M. O’Donovan(University of Toledo), Ojal Kakrecha(University of Toledo), Nicholas Henkel(University of Toledo), Robert E. McCullumsmith(Neurosciences Institute), Karen Bach(University of Toledo), Xiaojun Wu(University of Toledo)
Cited by 8
Related Papers
Bilirubin in the Liver–Gut Signaling Axis
|Trends in Endocrinology and Metabolism|2018|254
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
|Neuropsychopharmacology|2013|120
Biliverdin reductase and bilirubin in hepatic disease
|American Journal of Physiology-Gastrointestinal and Liver Physiology|2018|100
Bilirubin remodels murine white adipose tissue by reshaping mitochondrial activity and the coregulator profile of peroxisome proliferator–activated receptor α
|Journal of Biological Chemistry|2020|97
Signature-based approaches for informed drug repurposing: targeting CNS disorders
|Neuropsychopharmacology|2020|68